Pitfalls of predicting complex traits from SNPs

The success of genome-wide association studies (GWASs) has led to increasing interest in making predictions of complex trait phenotypes, including disease, from genotype data. Rigorous assessment of the value of predictors is crucial before implementation. Here we discuss some of the limitations and pitfalls of prediction analysis and show how naive implementations can lead to severe bias and misinterpretation of results

Nutrition and cancer: A review of the evidence for an anti-cancer diet

It has been estimated that 30–40 percent of all cancers can be prevented by lifestyle and dietary measures alone. Obesity, nutrient sparse foods such as concentrated sugars and refined flour products that contribute to impaired glucose metabolism (which leads to diabetes), low fiber intake, consumption of red meat, and imbalance of omega 3 and omega 6 fats all contribute to excess cancer risk. Intake of flax seed, especially its lignan fraction, and abundant portions of fruits and vegetables will lower cancer risk. Allium and cruciferous vegetables are especially beneficial, with broccoli sprouts being the densest source of sulforophane. Protective elements in a cancer prevention diet include selenium, folic acid, vitamin B-12, vitamin D, chlorophyll, and antioxidants such as the carotenoids (α-carotene, β-carotene, lycopene, lutein, cryptoxanthin). Ascorbic acid has limited benefits orally, but could be very beneficial intravenously. Supplementary use of oral digestive enzymes and probiotics also has merit as anticancer dietary measures. When a diet is compiled according to the guidelines here it is likely that there would be at least a 60–70 percent decrease in breast, colorectal, and prostate cancers, and even a 40–50 percent decrease in lung cancer, along with similar reductions in cancers at other sites. Such a diet would be conducive to preventing cancer and would favor recovery from cancer as well

A systematic review of randomised controlled trials assessing effectiveness of prosthetic and orthotic interventions.

BACKGROUND: Assistive products are items which allow older people and people with disabilities to be able to live a healthy, productive and dignified life. It has been estimated that approximately 1.5% of the world's population need a prosthesis or orthosis. OBJECTIVE: The objective of this study was to systematically identify and review the evidence from randomized controlled trials assessing effectiveness and cost-effectiveness of prosthetic and orthotic interventions. METHODS: Literature searches, completed in September 2015, were carried out in fourteen databases between years 1995 and 2015. The search results were independently screened by two reviewers. For the purpose of this manuscript, only randomized controlled trials which examined interventions using orthotic or prosthetic devices were selected for data extraction and synthesis. RESULTS: A total of 342 randomised controlled trials were identified (319 English language and 23 non-English language). Only 4 of these randomised controlled trials examined prosthetic interventions and the rest examined orthotic interventions. These orthotic interventions were categorised based on the medical conditions/injuries of the participants. From these studies, this review focused on the medical condition/injuries with the highest number of randomised controlled trials (osteoarthritis, fracture, stroke, carpal tunnel syndrome, plantar fasciitis, anterior cruciate ligament, diabetic foot, rheumatoid and juvenile idiopathic arthritis, ankle sprain, cerebral palsy, lateral epicondylitis and low back pain). The included articles were assessed for risk of bias using the Cochrane Risk of Bias tool. Details of the clinical population examined, the type of orthotic/prosthetic intervention, the comparator/s and the outcome measures were extracted. Effect sizes and odds ratios were calculated for all outcome measures, where possible. CONCLUSIONS: At present, for prosthetic and orthotic interventions, the scientific literature does not provide sufficient high quality research to allow strong conclusions on their effectiveness and cost-effectiveness

Biodiversity of benthic macro-and microalgae from Svalbard with special focus on Kongsfjorden

Several floristic studies on macroalgae of Svalbard have been published, but as access to the archipelago is difficult, these studies are scattered and often only cover single sites and habitats. Kongsfjorden, Isfjorden and Hornsund are the three most comprehensively investigated areas, and most of the species information comes from these three fjords. Quantitative and structured sublittoral sampling has been undertaken along depth transects and along the fjord only in Kongsfjorden. Clear dif-ferences are found from the outer to the inner parts of the fjord. Macroalgal biodiversity data from Kongsfjorden are presented in detail and compared to data for the whole archipelago. In total 197 species of macroalgae have been recorded for Svalbard; 84 of these occur in Kongsfjorden. The current taxonomic status of some species is discussed. Changes in the macroalgal flora during the last decades for Svalbard in general and in Kongsfjorden in particular, are summarised and possible causes discussed. Information on biodiversity of microphytobenthos is very scarce, and investigations in Kongsfjorden on benthic diatoms from soft bottom and biotic surfaces provide the first floristic information available. A total of 69 diatoms species have been identified and form a first baseline for a high-latitude fjord system. Biodiversity is relatively low compared to other sandy marine shallow water areas of temperate regions as indicated by the Shannon-Weaver index. Some data on epiphytic diatoms colonising seaweeds are available. Benthic diatoms colonise large parts of Kongsfjorden in high abundances and, in addition to macroalgae, are important as primary producers and therefore also for trophic relationships in the harsh Arctic environment